Operose Advisors’s Canopy Growth CGC Stock Holding History

Operose Advisors’s Portfolio CGC Stock Details CGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-47	Closed	-$368	–	628
2023 Q3	$368	Hold	47	–	–	﹤0.01%	744
2023 Q2	$182	Hold	47	–	–	﹤0.01%	353
2023 Q1	$823	Hold	47	–	–	﹤0.01%	328
2022 Q4	$1.09K	Buy	+47	New	+$1.45K	﹤0.01%	338

Other funds holding CGC

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

AXS Investments Port Chester, New York $353M AUM 34.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AAI

Aequim Alternative Investments Mill Valley, California $6.43B AUM 16.26% 1-Year Est. Return

Operose Advisors's CGC Position: Q4 2023 in Review

Operose Advisors sold out of Canopy Growth (CGC) in Q4 2023, closing a stake of 47 shares — an estimated $368 sold.

Operose Advisors first reported a position in CGC in Q4 2022 and held it in 4 quarters. The position peaked at $1.09K in Q4 2022. 229 funds tracked by Wall St. Rank hold CGC as of Q4 2023.

Operose Advisors reported no remaining Canopy Growth position as of Q4 2023 after selling out during the quarter.
Operose Advisors sold 47 Canopy Growth shares in Q4 2023, an estimated $368.
Operose Advisors first reported a position in Canopy Growth in Q4 2022 and held it in 4 quarters.
Operose Advisors's Canopy Growth position peaked at $1.09K in Q4 2022.
229 funds tracked by Wall St. Rank held Canopy Growth as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.